Evidence map›Paper›PMID 37349795›Full record

SynthesisMolecular neurodegeneration2023

A genome-wide search for pleiotropy in more than 100,000 harmonized longitudinal cognitive domain scores.

Moonil Kang, Ting Fang Alvin Ang, Sherral A Devine, Richard Sherva, Shubhabrata Mukherjee, Emily H Trittschuh, Laura E Gibbons, Phoebe Scollard, Michael Lee, Seo-Eun Choi and 19 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Molecular neurodegeneration, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Cardiovascular risk and hippocampal-cognitive coupling in Alzheimer's disease.medRxiv : the preprint server for health sciences · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Beyond NACC's Uniform Data Set for cognition: the impact of additional items on measurement precision.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  11. Genome-wide pleiotropy analysis of longitudinal blood pressure and harmonized cognitive performance measures.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  12. Article
  13. Article
  14. Plasma protein risk scores for mild cognitive impairment and Alzheimer's disease in the Framingham heart study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 10 institutions in 1 country.

Moonil KangDepartment of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, 72 East Concord Street E200, Boston, MA, 02118, USA.
Ting Fang Alvin AngDepartment of Anatomy and Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Sherral A DevineDepartment of Anatomy and Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Richard ShervaDepartment of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, 72 East Concord Street E200, Boston, MA, 02118, USA.
Shubhabrata MukherjeeDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Emily H TrittschuhGeriatric Research, Education, and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.
Laura E GibbonsDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Phoebe ScollardDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Michael LeeDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Seo-Eun ChoiDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Brandon KlinedinstDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Connie NakanoDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Logan C DumitrescuVanderbilt Memory & Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Alaina DurantVanderbilt Memory & Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Timothy J HohmanVanderbilt Memory & Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Michael L CuccaroJohn P. Hussman Institute for Human Genomics, Miller School of Medicine, Miami, FL, USA.
Andrew J SaykinIndiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA.
Walter A KukullDepartment of Epidemiology, University of Washington, Seattle, WA, USA.
David A BennettRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Li-San WangDepartment of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Richard P MayeuxDepartment of Neurology, Columbia University School of Medicine, New York, NY, USA.
Jonathan L HainesCleveland Institute for Computational Biology, Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
Margaret A Pericak-VanceJohn P. Hussman Institute for Human Genomics, Miller School of Medicine, Miami, FL, USA.
Gerard D SchellenbergDepartment of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Paul K CraneDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Rhoda AuDepartment of Anatomy and Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Kathryn L LunettaFramingham Heart Study, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Jesse B Mez *Framingham Heart Study, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Lindsay A Farrer *Department of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, 72 East Concord Street E200, Boston, MA, 02118, USA. farrer@bu.edu.ORCID 0000-0001-5533-4225
University of Washington · USBoston University · USVanderbilt University Medical Center · USDr. John T. Macdonald Foundation · USUniversity of Pennsylvania · USCase Western Reserve University · USColumbia University · USIndiana University School of MedicineRush University Medical Center · USUniversity of Puget Sound · US

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
NATIONAL ALZHEIMERS COORDINATING CENTER (NACC)U01AG016976 · NIA · UNIVERSITY OF WASHINGTON · PI KUKULL, WALTER ANTHONY · 1999 to 2020
$72.8M
Alzheimer's Disease Genetics ConsortiumU01AG032984 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2024
$60.4M
TBDU19AG068753 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Lindsay A. Farrer · 2020 to 2026
$42.4M
THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITEU24AG041689 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LI-SAN WANG · 2012 to 2026
$42.3M
MVP Data Integration into the ADSP Phenotype Harmonization ConsortiumU24AG074855 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CUCCARO, MICHAEL L, HOHMAN, TIMOTHY J · 2021 to 2025
$37.5M
Genome Center for Alzheimer's Disease (GCAD)U54AG052427 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID, WANG, LI-SAN · 2016 to 2025
$32.8M
Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease BiobanksU01AG068057 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Christos Davatzikos, Heng Huang · 2020 to 2026
$20.7M
The Alzheimer Disease Sequence Analysis CollaborativeU01AG058654 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI BUSH, WILLIAM S, FARRER, LINDSAY A. · 2018 to 2022
$14.6M
Genetic Studies of Alzheimer Disease in KoreansU01AG062602 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARRER, LINDSAY A. · 2019 to 2023
$9.5M
Alzheimer Disease Genetic Architecture in African AmericansR01AG048927 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Lindsay A. Farrer · 2015 to 2026
$8.4M
Leveraging Existing Aging Research Networks to investigate TBI and AD/ADRD risk (LEARN TBI & AD)R01AG061028 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAMS-O'CONNOR, KRISTEN, MEZ, JESSE BENJAMIN · 2019 to 2023
$5.9M
NIA NIH HHS P30-AG072878NIA NIH HHS R01 AG048927NIA NIH HHS R01-AG048927NIA NIH HHS R01 AG059716NIA NIH HHS R01-AG059716NIA NIH HHS R01 AG061028NIA NIH HHS R01 AG073439NIA NIH HHS RF1 AG057519NIA NIH HHS RF1-AG057519NIA NIH HHS U01 AG016976NIA NIH HHS U01 AG032984NIA NIH HHS U01-AG032984NIA NIH HHS U01 AG058654NIA NIH HHS U01-AG058654NIA NIH HHS U01 AG062602NIA NIH HHS U01-AG062602NIA NIH HHS U01 AG068057NIA NIH HHS U01-AG068057NIA NIH HHS U19 AG068753NIA NIH HHS U19-AG068753NIA NIH HHS U24 AG021886NIA NIH HHS U24 AG041689NIA NIH HHS U24 AG074855NIA NIH HHS U24-AG074855NIA NIH HHS U54 AG052427NIA NIH HHS U54-AG052427
6 · The paper itself

Abstract

backgroundMore than 75 common variant loci account for only a portion of the heritability for Alzheimer's disease (AD). A more complete understanding of the genetic basis of AD can be deduced by exploring associations with AD-related endophenotypes.

methodsWe conducted genome-wide scans for cognitive domain performance using harmonized and co-calibrated scores derived by confirmatory factor analyses for executive function, language, and memory. We analyzed 103,796 longitudinal observations from 23,066 members of community-based (FHS, ACT, and ROSMAP) and clinic-based (ADRCs and ADNI) cohorts using generalized linear mixed models including terms for SNP, age, SNP × age interaction, sex, education, and five ancestry principal components. Significance was determined based on a joint test of the SNP's main effect and interaction with age. Results across datasets were combined using inverse-variance meta-analysis. Genome-wide tests of pleiotropy for each domain pair as the outcome were performed using PLACO software.

resultsIndividual domain and pleiotropy analyses revealed genome-wide significant (GWS) associations with five established loci for AD and AD-related disorders (BIN1, CR1, GRN, MS4A6A, and APOE) and eight novel loci. ULK2 was associated with executive function in the community-based cohorts (rs157405, P = 2.19 × 10

conclusionOur results provide some insight into biological pathways underlying processes leading to domain-specific cognitive impairment and AD, as well as a conduit toward a syndrome-specific precision medicine approach to AD. Increasing the number of participants with harmonized cognitive domain scores will enhance the discovery of additional genetic factors of cognitive decline leading to AD and related dementias.

Indexed as

Alzheimer DiseaseGenome-Wide Association StudyCognitionCyclin-Dependent KinasesFemaleHumansMaleCDK14 protein, humanCyclin-Dependent KinasesAlzheimer’s diseaseCognitive domainsGenome-wide association studyLongitudinal measuresPathway analysisPleiotropy

Identifiers

PMID37349795
PMCPMC10286470
OpenAlexW4381716608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.